SOX4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.813800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.955370E-01
Normal-vs-Stage2
5.015000E-01
Normal-vs-Stage3
4.089000E-01
Normal-vs-Stage4
6.095400E-01
Stage1-vs-Stage2
3.320600E-01
Stage1-vs-Stage3
5.857800E-01
Stage1-vs-Stage4
3.888000E-01
Stage2-vs-Stage3
9.337600E-01
Stage2-vs-Stage4
5.113600E-01
Stage3-vs-Stage4
7.097000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.653200E-01
Normal-vs-AfricanAmerican
5.059600E-01
Normal-vs-Asian
4.645200E-01
Caucasian-vs-AfricanAmerican
2.151000E-01
Caucasian-vs-Asian
3.266200E-01
AfricanAmerican-vs-Asian
9.540000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.982000E-01
Normal-vs-Female
4.666800E-01
Male-vs-Female
4.997400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.624000E-01
Normal-vs-Age(41-60Yrs)
5.662400E-01
Normal-vs-Age(61-80Yrs)
4.503600E-01
Normal-vs-Age(81-100Yrs)
1.699180E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.544800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.952000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.793000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.899700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.511800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.362200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.697800E-01
Normal-vs-Daily Drinker
3.960200E-01
Normal-vs-Weekly Drinker
4.143400E-01
Normal-vs-Occasional Drinker
5.000600E-01
Normal-vs-Social Drinker
4.950400E-01
Non Drinker-vs-Daily Drinker
2.526800E-01
Non Drinker-vs-Weekly Drinker
4.587800E-01
Non Drinker-vs-Occasional Drinker
7.412600E-01
Non Drinker-vs-Social Drinker
8.001800E-01
Daily Drinker-vs-Weekly Drinker
7.977000E-01
Daily Drinker-vs-Occasional Drinker
1.955820E-01
Daily Drinker-vs-Social Drinker
2.315200E-01
Weekly Drinker-vs-Occasional Drinker
3.579200E-01
Weekly Drinker-vs-Social Drinker
3.951600E-01
Occasional Drinker-vs-Social Drinker
9.574600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.285400E-01
Normal-vs-Grade 2
2.354200E-02
Normal-vs-Grade 3
3.858200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.055600E-01
Grade 1-vs-Grade 3
9.036000E-02
Grade 1-vs-Grade 4
2.285400E-01
Grade 2-vs-Grade 3
1.589190E-01
Grade 2-vs-Grade 4
2.354200E-02
Grade 3-vs-Grade 4
3.858200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.533400E-01
Normal-vs-NonDiabetic
4.877200E-01
Diabetic-vs-NonDiabetic
5.125800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.727400E-01
Normal-vs-NoPancreatitis
4.781000E-01
Pancreatitis-vs-NoPancreatitis
9.013000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.508600E-01
Normal-vs-N1
5.066200E-01
N0-vs-N1
2.708400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.485400E-01
Normal-vs-TP53-NonMutant
3.587400E-01
TP53-Mutant-vs-TP53-NonMutant
4.39620000000085E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
